- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00165061
Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)
Phase 3 Multicenter Randomized Study Comparing Esophagectomy Against Definitive Chemoradiation for Treatment of Squamous Esophageal Cancer
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Cancer of the oesophagus is notorious for its grave prognosis with an overall 5-year survival rate of 10-20%. Surgical resection with curative intent remains the most effective treatment for this disease. To improve the survival, a better treatment approach is in need to manage patients with oesophageal cancer. Unfortunately, the use of preoperative adjuvant chemotherapy or adjuvant radiotherapy does not confer any survival benefit to patients with localized oesophageal cancer as proven in most randomized studies. However, the combination of chemotherapy and radiotherapy has greater clinical efficacy in achieving complete pathological regression of the tumour as well as the response rate as shown in our preliminary results. In fact, treatment of squamous oesophageal cancer by primary chemo-irradiation without surgery is now feasible.
We propose to conduct a multi-center randomized trial to evaluate the efficacy and the patients' survival by comparing primary chemo-irradiation without surgery versus standard surgical resection as the treatment for squamous oesophageal cancer. Those patients with residual cancer after primary chemo-irradiation will have salvage oesophagectomy to control the disease. Over a 3-year period, a total of 80 patients will be recruited from 4 different hospitals with 100 patients being randomized into each treatment arm. Treatment outcomes will be compared on an intention-to-treat analysis basis.
Studietyp
Inskrivning
Fas
- Fas 3
Kontakter och platser
Studieorter
-
-
-
Hong Kong, Kina
- Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- mid or lower thoracic esophageal cancers that were confirmed on histology to be a squamous cell carcinoma deemed to be resectable
Exclusion Criteria:
- distant metastasis to solid visceral organs
- local invasion into trachea, descending aorta or recurrent laryngeal nerve.
- patients > 75 years
- serious premorbid condition
- poor physical status that compromised a thoracotomy
- compromised cardiac function
- creatinine clearance less than 50 ml/min were not eligible.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vad mäter studien?
Primära resultatmått
Resultatmått |
---|
Total överlevnad
|
Sekundära resultatmått
Resultatmått |
---|
1.Disease free survival
|
2.Hospital stay
|
3.Morbidities
|
4.Recurrence of the disease
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Philip WY Chiu, MBChB, FRCSEd, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong
- Studierektor: Angus CW Chan, MD, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong
Studieavstämningsdatum
Studera stora datum
Studiestart
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- CRE-9362
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Matstrupscancer
-
The Cleveland ClinicMedtronic - MITGAvslutadEsophageal lesionFörenta staterna
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)AvslutadSteg IIIA Esophageal Adenocarcinom | Steg IIIB Esophageal Adenocarcinom | Steg IIIC Esophageal Adenocarcinom | Steg IIB Esophageal Adenocarcinom | Steg IB Esophageal Adenocarcinom | Steg IIA Esophageal AdenocarcinomFörenta staterna
-
NYU Langone HealthIndragen
-
Biomerics, LLCOkänd
-
Region Örebro CountyAvslutadNedre Esophageal SphincterSverige
-
University of Massachusetts, WorcesterAvslutadEsophageal dysmotilitetFörenta staterna
-
Augusta UniversityAvslutadEsophageal dysmotilitetFörenta staterna
-
Dartmouth-Hitchcock Medical CenterIndragenGastro Esophageal Reflux Disease PPI Non-Responders
-
HealthPartners InstituteAvslutad
-
Nanfang Hospital of Southern Medical UniversityOkändEsophageal motilitetsstörning | Esophageal AchalasiaKina
Kliniska prövningar på Esophagectomy
-
Shanghai Zhongshan HospitalZhejiang Cancer Hospital; Sun Yat-sen University; Cancer Institute and Hospital... och andra samarbetspartnersRekryteringEsofagus skivepitelcancer Steg II | Esofagus skivepitelcancer Steg IIIKina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RekryteringEsophagogastric Junction CarcinomaKina